Serial Measurements of Protein Biomarkers in Sepsis-Induced Acute Respiratory Distress Syndrome

Overview

Journal Crit Care Explor

Specialty Critical Care

Date 2022 Oct 26

PMID 36284549

Authors

Philip Yang

Elizabeth Iffrig

Frank Harris

Andre L Holder

Greg S Martin

Annette M Esper

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine the differences in soluble receptor for advanced glycation end-products (sRAGEs), angiopoietin-2, and surfactant protein-D (SP-D) levels and their changes over time between sepsis patients with and without ARDS.

Design Setting And Participants: Prospective observational cohort study of adult patients admitted to the medical ICU at Grady Memorial Hospital within 72 hours of sepsis diagnosis.

Main Outcomes And Measures: Plasma sRAGE, angiopoietin-2, and SP-D levels were measured for 3 consecutive days after enrollment. The primary outcome was ARDS development, and the secondary outcome of 28-day mortality. The biomarker levels and their changes over time were compared between ARDS and non-ARDS patients and between nonsurvivors and survivors.

Results: We enrolled 111 patients, and 21 patients (18.9%) developed ARDS. The three biomarker levels were not significantly different between ARDS and non-ARDS patients on all 3 days of measurement. Nonsurvivors had higher levels of all three biomarkers than did survivors on multiple days. The changes of the biomarker levels over time were not different between the outcome groups. Logistic regression analyses showed association between day 1 SP-D level and mortality (odds ratio, 1.52; 95% CI, 1.03-2.24; = 0.03), and generalized estimating equation analyses showed association between angiopoietin-2 levels and mortality (estimate 0.0002; se 0.0001; = 0.04).

Conclusions And Relevance: Among critically ill patients with sepsis, sRAGE, angiopoietin-2, and SP-D levels were not significantly different between ARDS and non-ARDS patients but were higher in nonsurvivors compared with survivors. The trend toward higher levels of sRAGE and SP-D, but not of angiopoietin-2, in ARDS patients may indicate the importance of epithelial injury in sepsis-induced ARDS. Changes of the biomarker levels over time were not different between the outcome groups.

Citing Articles

Inflammatory and tissue injury marker dynamics in pediatric acute respiratory distress syndrome.

Yehya N, Booth T, Ardhanari G, Thompson J, Lam L, Till J J Clin Invest. 2024; 134(10).

PMID: 38573766 PMC: 11093602. DOI: 10.1172/JCI177896.

Interferon-dependent signaling is critical for viral clearance in airway neutrophils.

Margaroli C, Fram T, Sharma N, Patel S, Tipper J, Robison S JCI Insight. 2023; 8(10).

PMID: 37071484 PMC: 10322684. DOI: 10.1172/jci.insight.167042.

References

Jones T, Feng R, Kerchberger V, Reilly J, Anderson B, Shashaty M . Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2019; 201(1):47-56. PMC: 6938154. DOI: 10.1164/rccm.201810-2033OC. View

Calfee C, Gallagher D, Abbott J, Thompson B, Matthay M . Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med. 2012; 40(6):1731-7. PMC: 3601049. DOI: 10.1097/CCM.0b013e3182451c87. View

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

Bellani G, Laffey J, Pham T, Fan E, Brochard L, Esteban A . Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016; 315(8):788-800. DOI: 10.1001/jama.2016.0291. View

Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A . Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med. 2011; 39(3):480-8. DOI: 10.1097/CCM.0b013e318206b3ca. View

van der Heijden M, van Nieuw Amerongen G, Koolwijk P, van Hinsbergh V, Groeneveld A . Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax. 2008; 63(10):903-9. DOI: 10.1136/thx.2007.087387. View

Knaus W, Draper E, Wagner D, Zimmerman J . APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10):818-29. View

Jabaudon M, Blondonnet R, Pereira B, Cartin-Ceba R, Lichtenstern C, Mauri T . Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data. Intensive Care Med. 2018; 44(9):1388-1399. PMC: 6132684. DOI: 10.1007/s00134-018-5327-1. View

Park J, Pabon M, Choi A, Siempos I, Fredenburgh L, Baron R . Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts. BMC Pulm Med. 2017; 17(1):204. PMC: 5731189. DOI: 10.1186/s12890-017-0532-1. View

10.

Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, Fan E . Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23):2526-33. DOI: 10.1001/jama.2012.5669. View

11.

Shari G, Kojicic M, Li G, Cartin-Ceba R, Alvarez C, Kashyap R . Timing of the onset of acute respiratory distress syndrome: a population-based study. Respir Care. 2011; 56(5):576-82. DOI: 10.4187/respcare.00901. View

12.

van der Heijden M, Pickkers P, van Nieuw Amerongen G, van Hinsbergh V, Bouw M, van der Hoeven J . Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med. 2009; 35(9):1567-74. PMC: 2726915. DOI: 10.1007/s00134-009-1560-y. View

13.

Vincent J, Moreno R, Takala J, Willatts S, de Mendonca A, Bruining H . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22(7):707-10. DOI: 10.1007/BF01709751. View

14.

Terpstra M, Aman J, van Nieuw Amerongen G, Groeneveld A . Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*. Crit Care Med. 2013; 42(3):691-700. DOI: 10.1097/01.ccm.0000435669.60811.24. View

15.

Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Maeda S, Yamagishi S . Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clin Biochem. 2011; 44(8-9):601-4. DOI: 10.1016/j.clinbiochem.2010.12.014. View

16.

Sheu C, Gong M, Zhai R, Chen F, Bajwa E, Clardy P . Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest. 2010; 138(3):559-67. PMC: 2940067. DOI: 10.1378/chest.09-2933. View

17.

Calfee C, Janz D, Bernard G, May A, Kangelaris K, Matthay M . Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015; 147(6):1539-1548. PMC: 4451708. DOI: 10.1378/chest.14-2454. View

18.

Agrawal A, Matthay M, Kangelaris K, Stein J, Chu J, Imp B . Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med. 2013; 187(7):736-42. PMC: 3678110. DOI: 10.1164/rccm.201208-1460OC. View

19.

Ricciuto D, Santos C, Hawkes M, Toltl L, Conroy A, Rajwans N . Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med. 2011; 39(4):702-10. DOI: 10.1097/CCM.0b013e318206d285. View

20.

Reilly J, Calfee C, Christie J . Acute Respiratory Distress Syndrome Phenotypes. Semin Respir Crit Care Med. 2019; 40(1):19-30. PMC: 6657496. DOI: 10.1055/s-0039-1684049. View